This program has helped finance research projects developed by the Group IDIVAL Infection and Immunity and Digestive Pathology
The results of this Group in 2015 have been highlighting notable scientific production of more than 100 points of impact and funding from the Health Institute Carlos III, which exceeds € 600,000 for the development of an integrated project of excellence that I begin in 2016, focusing on the study of hepatitis C with the participation of half a dozen researchers responsible for IDIVAL Groups
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del...
Theriva™ Biologics has announced the presentation of preclinical da...
Biotechnology portal in Spain
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Biotech-Spain.com - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory